FDA 483 - Avista Pharma Solutions, Inc. dba Cambrex - September 27, 2013
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Microtest Laboratories, Inc. in Agawam, MA, was inspected by the FDA from September 16-27, 2013, and received eight observations. The inspection revealed significant deficiencies in quality control, aseptic processing, environmental monitoring, and validation of sterile drug product manufacturing. Key issues include releasing sterile injectable products without complete testing, inadequate smoke studies, and failures in investigating discrepancies and validating sterilization processes.
- Inspection Date
- September 27, 2013
- Product Type
- Biologics
ID · 9f9dbbb7-e4b8-44a3-81c1-7d55709ef9c2